Biothrax Market Report 2026

Biothrax Market Overview

• The Biothrax market growth in the historic period has been driven by bioterrorism threat awareness, government-funded vaccine programs • Market expansion is supported by increased homeland security investments, rising global biodefense collaborations • Growth Driver: Impact of Meat Consumption on the Biothrax Market Growth • Market Trend: Strategic Investments Driving Growth in the Biothrax Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Biothrax Market?

Biothrax is a vaccine designed to protect against anthrax, a serious and potentially fatal illness caused by the bacterium Bacillus anthracis. The vaccine works by stimulating the immune system to produce antibodies against anthrax toxins, which can be deadly if exposure occurs, especially in cases of bioterrorism. The main types in the biothrax market are live vaccines and cell free protective antigen vaccines. Live vaccines are made from weakened (attenuated) organisms that no longer cause disease but effectively stimulate a robust immune response. The clinical indication are pre-exposure prophylaxis and post-exposure prophylaxis. The various applications include human use and animal use, and several end-users encompass hospitals, clinics, vaccination centers, and others.

What Is The Biothrax Market Growth Forecast?

The biothrax market size is expected to see strong growth in the next few years. It will grow to $1.4 million in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increased homeland security investments, rising global biodefense collaborations, expansion of emergency preparedness policies, growth in animal anthrax prevention programs, modernization of vaccine storage infrastructure. Major trends in the forecast period include rising focus on biodefense preparedness, expansion of government stockpiling programs, increased use of pre-exposure prophylaxis vaccination, growing emphasis on emergency response readiness, strengthening of national immunization security programs.

Global Biothrax Market Segmentation

1) By Type: Live Vaccines, Cell Free Protective Antigen Vaccines 2) By Clinical Indication: Pre-Exposure Prophylaxis, Post-Exposure Prophylaxis 3) By Application: Human Use, Animal Use 4) By End-User: Hospital, Clinics, Vaccination Centers, Other End-Users

What Are The Drivers Of The Biothrax Market?

Increasing consumption of meat is expected to drive the growth of the biothrax market going forward. Meat consumption is attributed to factors such as increasing urbanization, rising income levels, evolving dietary preferences, and cultural traditions emphasizing meat as a primary source of protein and nutrition. BioThrax is used to vaccinate livestock against anthrax, a disease that can spread through contaminated meat, thereby ensuring the safety of meat products and protecting public health from zoonotic disease outbreaks. For instance, in June 2023, according to a report published by the Food and Agriculture Organization of the United Nations (FAO), a US-based agency that specializes in promoting food security, sustainable agriculture, and rural development, global meat production rose from 356.9 million metric tons in 2021 to 363.9 million metric tons in 2023, reflecting a 1.96% increase. Specifically, global bovine meat production increased from 74.9 million metric tons in 2021 to 76.1 million metric tons in 2023. Thus, increasing consumption of meat is driving the growth of the biothrax industry. Growing prevalence of anthrax is expected to propel the growth of the biothrax market going forward. The prevalence of anthrax is primarily due to the presence of Bacillus anthracis spores in soil. Biothrax is a vaccine that helps prevent anthrax by stimulating the immune system to produce antibodies against Bacillus anthracis, providing protection against potential infection. For instance, in December 2023, according to the World Health Organization, a Switzerland-based intergovernmental organization, as of November 2023, Zambia reported 684 suspected human cases of anthrax, including four deaths, resulting in a case fatality ratio (CFR) of 0.6%. Thus, growing prevalence of anthrax is driving the growth of the biothrax industry.

Key Players In The Global Biothrax Market

Major companies operating in the biothrax market are Emergent Bio-Solutions

Global Biothrax Market Trends and Insights

The key trend in the biothrax market is focusing on strategic investments to enhance production capabilities, expand their geographic presence, and develop advanced anthrax vaccines. Strategic funding supports clinical trials and regulatory compliance, enabling companies to gain approvals in multiple countries. This expands the availability of vaccines to underserved regions. For instance, in January 2024, Emergent BioSolutions, a US-based biotech company, was awarded a significant contract worth up to $235.8 million by the U.S. Department of Defense (DoD) to supply BioThrax (Anthrax Vaccine Adsorbed) for military use. This contract underscores the ongoing need for effective anthrax vaccines within the U.S. military and reflects Emergent's long-standing relationship with government agencies in providing biodefense solutions.

Regional Insights

North America was the largest region in the biothrax market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Biothrax Market?

The biothrax market consists of sales of single-dose vials and multi-dose vials. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Biothrax Market Report 2026?

The biothrax market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biothrax industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.